Genmab, DK0010272202

Genmab stock gains 0.8 percent ahead of the open

Published on 09/25/2026 at 02:23 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

At the close on September 24, 2026, Genmab stock was valued at DKK 2,268, while a company announcement disclosed employee awards tied to that closing price.

Fotorealistisches Biotech-Labor mit Forschern in weißen Kitteln bei Antikörperforschung
Genmab A/S entwickelt Antikörpertherapien in modernen Biotech-Laboren mit Forschern und Präzisionsgeräten, Aktie DK0010272202, Illustration mit AI erstellt.

Genmab stock closed at DKK 2,268 on Nasdaq Copenhagen on September 24, 2026, with the session change reported as 0.8 percent. The closing price also served as the fair value and exercise price for awards disclosed by the company.

September 24, 2026 in numbers

Genmab A/S (ISIN DK0010272202) ended the September 24 session at DKK 2,268. The same dated market figure was used for 13,794 restricted stock units and 13,331 warrants granted to employees and subsidiaries.

As Taiwan News reported on September 25, 2026, Genmab said the awards were decided on September 24, 2026. The warrants carry an exercise price of DKK 2,268 and a stated fair value of DKK 781.96.

Genmab event today

The employee award announcement was published on September 25, 2026, before the US market open. StockTitan carries the related Form 6-K dated September 24, 2026, identifying the announcement as Company Announcement number 38.

Disclaimer...

en | DK0010272202 | GENMAB | boerse | 70179826 | bgmi